ସନ୍ଧାନ କର | (ସମ୍ବାଦ)

Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform

english health

Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages Based on the initial arrangements, the total invoiced amount expected to be achieved by Henlius in 2026 is...
2026-08-17 04:08:00